The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.
Bradi L. Frei, PharmD, MS
Advertisement
Articles by Bradi L. Frei, PharmD, MS
Advertisement
Latest Updated Articles
- Cost of Squamous Cell Cancer of the Head and Neck
Published: June 22nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
From Mutation to Medicine: Targeted Therapies in Lung Cancer
4
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
5
